MWG Biotech AG - Continuation of lab automation line secured through AVISO GmbH

08-Feb-2005

MWG Biotech AG announces the transfer of its lab automation business to the automation specialist AVISO GmbH effective February 1. With this transaction the international continuation of the innovative robotics line is secured on a high quality level through AVISO GmbH. AVISO will also take over 15 of MWG Biotech's former lab automation employees. All servicing and warranty services will be continued by AVISO GmbH. In the Western part of the US Synquatech Inc, a spin-out of MWG employees led by Michael Winniman, will take over the lab automation services and sales as an AVISO partner. All other areas will be directly served by AVISO. Transaction details were not disclosed.

"With this transaction MWG Biotech AG closes a major chapter of its restructuring process. At the same time this solution ensures that MWG Biotech's PCR and liquid handling system customers will continue to receive competent high quality services. We are happy that the innovative THEONYX Liquid Handling platform will now be further developed in the market by AVISO GmbH ", says Dr. Wolfgang Pieken, Speaker of the Management Board of MWG Biotech AG.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances